Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Central Serous Chorioretinopathy clinical trials
Every US clinical trial registered for Central Serous Chorioretinopathy — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
6 US clinical trials · 1 currently recruiting
The research picture
Central Serous Chorioretinopathy has 6 registered US clinical trials, 1 of them open to new participants right now — about 17% of the total.
- 1
- recruiting participants now
- 17%
- of trials open to enrollment
- 0
- in Phase 3–4 (later-stage)
- 2
- top sponsor: Wills Eye
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
OCT in Rare Chorioretinal Diseases
Oregon Health and Science University
NCT02141308
Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
Sequenom
NCT01880788
Eplerenone for the Treatment of Central Serous Chorioretinopathy
Wills Eye
NCT01990677
Short-Term Oral Mifepristone for Central Serous Chorioretinopathy
Roger Goldberg, M.D., MBA
NCT02354170
The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy
Wills Eye
NCT01710332
Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy
Vitreous -Retina- Macula Consultants of New York
NCT00403325
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Central Serous Chorioretinopathy Trial Landscape
ClinicalTrials.gov lists 6 US studies indexed under Central Serous Chorioretinopathy, and 1 of those are currently open to recruitment — roughly 17% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Central Serous Chorioretinopathy shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 3 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Central Serous Chorioretinopathy is led by Wills Eye with 2 indexed trials, alongside 4 other organizations in the top contributor list. The list on this page surfaces up to 6 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Central Serous Chorioretinopathy?
PlainTrial tracks 6 US clinical trials for Central Serous Chorioretinopathy, of which 1 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Central Serous Chorioretinopathy?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.